{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:13:45Z","timestamp":1788686025027,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["TDK-2021-10284"],"award-info":[{"award-number":["TDK-2021-10284"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10528-026-11412-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:59:48Z","timestamp":1781233188000},"page":"7695-7719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fisetin Modulates Chemoresistance-Associated miR-21, miR-181a, miR-203, miR-101 and miR-381 in Capecitabine-Resistant HT29 Colorectal Cancer Cells"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5169-9999","authenticated-orcid":false,"given":"Zehra","family":"Kanl\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-9841","authenticated-orcid":false,"given":"\u0130rem Peker","family":"Ey\u00fcbo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6036-1348","authenticated-orcid":false,"given":"Kazim Yalcin","family":"Arga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3267-8620","authenticated-orcid":false,"given":"Banu","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7914-1169","authenticated-orcid":false,"given":"Can","family":"Erzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-2198","authenticated-orcid":false,"given":"H\u00fclya","family":"Cabadak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"4","key":"11412_CR1","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/ijms22041801","volume":"22","author":"A Barbato","year":"2021","unstructured":"Barbato A, Iuliano A, Volpe M, D\u2019Alterio R, Brillante S, Massa F, Carotenuto P (2021) Integrated genomics identifies miR-181\/TFAM pathway as a critical driver of drug resistance in melanoma. Int J Mol Sci 22(4):1801","journal-title":"Int J Mol Sci"},{"key":"11412_CR2","doi-asserted-by":"publisher","first-page":"107152","DOI":"10.1016\/j.compbiolchem.2019.107152","volume":"84","author":"SS Bhowmick","year":"2020","unstructured":"Bhowmick SS, Bhattacharjee D, Rato L (2020) Integrated analysis of the miRNA\u2013mRNA next-generation sequencing data for finding their associations in different cancer types. Comput Biol Chem 84:107152","journal-title":"Comput Biol Chem"},{"issue":"2","key":"11412_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ygyno.2009.01.014","volume":"113","author":"T Boren","year":"2009","unstructured":"Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Chan G, Lancaster JM (2009) MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol Oncol 113(2):249\u2013255","journal-title":"Gynecol Oncol"},{"issue":"6","key":"11412_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68(6):394\u2013424","journal-title":"Cancer J Clin"},{"issue":"9927","key":"11412_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383(9927):1490\u20131502","journal-title":"Lancet"},{"issue":"1","key":"11412_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2105-15-29","volume":"15","author":"PK Busk","year":"2014","unstructured":"Busk PK (2014) A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinf 15(1):29","journal-title":"BMC Bioinf"},{"issue":"7","key":"11412_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/genes14071375","volume":"14","author":"A Chakrabortty","year":"2023","unstructured":"Chakrabortty A, Patton DJ, Smith BF, Agarwal P (2023) miRNAs: potential as biomarkers and therapeutic targets for cancer. Genes (Basel) 14(7):1375","journal-title":"Genes (Basel)"},{"issue":"3","key":"11412_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ygyno.2014.01.034","volume":"132","author":"JK Chan","year":"2014","unstructured":"Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C, Bourguignon LY (2014) The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol Oncol 132(3):739\u2013744","journal-title":"Gynecol Oncol"},{"key":"11412_CR9","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.12659\/MSM.915524","volume":"25","author":"Y Chan","year":"2019","unstructured":"Chan Y, Yu Y, Wang G, Wang C, Zhang D, Wang X, Wang Z, Jian W, Zhang C (2019) Inhibition of microRNA-381 promotes tumor cell growth and chemoresistance in clear-cell renal cell carcinoma. Med Sci Monit 25:5181","journal-title":"Med Sci Monit"},{"issue":"5","key":"11412_CR10","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1111\/jcmm.14209","volume":"23","author":"H Chen","year":"2019","unstructured":"Chen H, Xu Z, Liu D (2019) Small non-coding RNA and colorectal cancer. J Cell Mol Med 23(5):3050\u20133057","journal-title":"J Cell Mol Med"},{"issue":"3","key":"11412_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.immuni.2013.08.025","volume":"39","author":"TX Cui","year":"2013","unstructured":"Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Zou W (2013) Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity 39(3):611\u2013621","journal-title":"Immunity"},{"issue":"5","key":"11412_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41576-020-00309-5","volume":"22","author":"B DeVeale","year":"2021","unstructured":"DeVeale B, Swindlehurst-Chan J, Blelloch R (2021) The roles of microRNAs in mouse development. Nat Rev Genet 22(5):307\u2013323","journal-title":"Nat Rev Genet"},{"issue":"1","key":"11412_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9950749","volume":"2021","author":"Y Dong","year":"2021","unstructured":"Dong Y, Gao Y, Xie T, Liu H, Zhan X, Xu Y (2021) miR-101\u20103p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2. BioMed Res Int 2021(1):9950749","journal-title":"BioMed Res Int"},{"issue":"2","key":"11412_CR14","first-page":"409","volume":"39","author":"U Drebber","year":"2011","unstructured":"Drebber U, Lay M, Wedemeyer I, VALLb\u00f6HMER D, Bollschweiler E, Brabender J, Odenthal M (2011) Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int J Oncol 39(2):409\u2013415","journal-title":"Int J Oncol"},{"issue":"1","key":"11412_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1186\/s12885-018-4758-y","volume":"18","author":"E Durinikova","year":"2018","unstructured":"Durinikova E, Kozovska Z, Poturnajova M, Plava J, Cierna Z, Babelova A, Matuskova M (2018) ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells. BMC Cancer 18(1):848","journal-title":"BMC Cancer"},{"issue":"5","key":"11412_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097094","volume":"9","author":"IM Echevarr\u00eda-Vargas","year":"2014","unstructured":"Echevarr\u00eda-Vargas IM, Valiyeva F, Vivas-Mej\u00eda PE (2014) Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1\/c-Jun pathway. PLoS ONE 9(5):e97094","journal-title":"PLoS ONE"},{"issue":"1","key":"11412_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1389450122666210412125018","volume":"23","author":"MM Estevinho","year":"2022","unstructured":"Estevinho MM, Fernandes C, Silva JC, Gomes AC, Afecto E, Correia J, Carvalho J (2022) Role of ATP-binding cassette transporters in sorafenib therapy for hepatocellular carcinoma: an overview. Curr Drug Targets 23(1):21\u201332","journal-title":"Curr Drug Targets"},{"issue":"1","key":"11412_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13065-020-00672-8","volume":"14","author":"Y Feng","year":"2020","unstructured":"Feng Y, Shu J, Yao L, Lan Y, Ye L, Mei W, Ding Y (2020) Recognizing and stabilizing miR-21 by chiral ruthenium (II) complexes. BMC Chem 14(1):26","journal-title":"BMC Chem"},{"issue":"44","key":"11412_CR19","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1038\/onc.2013.451","volume":"33","author":"A Formosa","year":"2014","unstructured":"Formosa A, Markert EK, Lena AM, Italiano D, Finazzi-Agro E, Levine AJ, Candi E (2014) MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32. 31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene 33(44):5173\u20135182","journal-title":"Oncogene"},{"issue":"10","key":"11412_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrd3179","volume":"9","author":"R Garzon","year":"2010","unstructured":"Garzon R, Marcucci G, Croce CM (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9(10):775\u2013789","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"11412_CR21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3892\/ijmm.2016.2557","volume":"37","author":"H Guan","year":"2016","unstructured":"Guan H, Dai Z, Ma Y, Wang Z, Liu X, Wang X (2016) MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer. Int J Mol Med 37(6):1643\u20131651","journal-title":"Int J Mol Med"},{"key":"11412_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2020.101451","volume":"67","author":"Q Guo","year":"2020","unstructured":"Guo Q, Yin X, Gao J, Wang X, Zhang S, Zhou X, Wang Z, Zhang Q (2020) MiR-381-3p redistributes between cytosol and mitochondria and aggravates endothelial cell injury induced by reactive oxygen species. Tissue Cell 67:101451","journal-title":"Tissue Cell"},{"issue":"8","key":"11412_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20(8):460\u2013469","journal-title":"Trends Mol Med"},{"issue":"52","key":"11412_CR24","doi-asserted-by":"publisher","first-page":"19075","DOI":"10.1073\/pnas.0509603102","volume":"102","author":"H He","year":"2005","unstructured":"He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu C, Franssila K, Suster S, Kloos RT, Croce CM, De La Chapelle A (2005) The role of microRNA genes in papillary thyroid carcinoma. Proceedings of the National Academy of Sciences 102(52):19075\u201319080","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"11412_CR25","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S99228","author":"X He","year":"2016","unstructured":"He X, Wei Y, Wang Y, Liu L, Wang W, Li N (2016) MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1. OncoTargets Ther. https:\/\/doi.org\/10.2147\/OTT.S99228","journal-title":"OncoTargets Ther"},{"issue":"3","key":"11412_CR26","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers 6(3):1769\u20131792","journal-title":"Cancers"},{"issue":"5","key":"11412_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/1120009X.2021.1899441","volume":"33","author":"Z Huang","year":"2021","unstructured":"Huang Z, Huang L, Liu L, Wang L, Lin W, Zhu X, Lv C (2021) Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX2. J Chemother 33(5):328\u2013341","journal-title":"J Chemother"},{"issue":"16","key":"11412_CR28","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065\u20137070","journal-title":"Cancer Res"},{"issue":"2","key":"11412_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.canlet.2013.02.059","volume":"335","author":"D Jiang","year":"2013","unstructured":"Jiang D, Sui M, Zhong W, Huang Y, Fan W (2013) Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells. Cancer Lett 335(2):404\u2013411","journal-title":"Cancer Lett"},{"issue":"3","key":"11412_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/humu.22021","volume":"33","author":"Z Kanaan","year":"2012","unstructured":"Kanaan Z, Rai SN, Eichenberger MR, Barnes C, Dworkin AM, Weller C, Cohen E, Roberts H, Keskey B, Petras RE, Crawford NPS, Galandiuk S (2012) Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat 33(3):551\u2013560","journal-title":"Hum Mutat"},{"issue":"10","key":"11412_CR31","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1007\/s00210-024-03145-0","volume":"397","author":"Z Kanl\u0131","year":"2024","unstructured":"Kanl\u0131 Z, Ayd\u0131n B, Erzik C, Cabadak H (2024) Fisetin and\/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines. Naunyn-Schmiedeberg\u2019s Archives Pharmacol 397(10):7913\u20137926","journal-title":"Naunyn-Schmiedeberg\u2019s Archives Pharmacol"},{"issue":"6","key":"11412_CR32","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/life12060897","volume":"12","author":"C Karthika","year":"2022","unstructured":"Karthika C, Sureshkumar R, Zehravi M, Akter R, Ali F, Ramproshad S, Cavalu S (2022) Multidrug resistance of cancer cells and the vital role of P-glycoprotein. Life 12(6):897","journal-title":"Life"},{"key":"11412_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lfs.2017.12.005","volume":"194","author":"D Kashyap","year":"2018","unstructured":"Kashyap D, Sharma A, Sak K, Tuli HS, Buttar HS, Bishayee A (2018) Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sci 194:75\u201387","journal-title":"Life Sci"},{"issue":"5","key":"11412_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biom9050174","volume":"9","author":"D Kashyap","year":"2019","unstructured":"Kashyap D, Garg VK, Tuli HS, Yerer MB, Sak K, Sharma AK, Kumar M, Aggarwal V, Sandhu SS (2019) Fisetin and quercetin: promising flavonoids with chemopreventive potential. Biomolecules 9(5):174","journal-title":"Biomolecules"},{"key":"11412_CR35","first-page":"114","volume-title":"Seminars in cell & developmental biology","author":"P Khan","year":"2022","unstructured":"Khan P, Ebenezer NS, Siddiqui JA, Maurya SK, Lakshmanan I, Salgia R, Nasser MW (2022) MicroRNA-1: diverse role of a small player in multiple cancers. Seminars in cell & developmental biology, vol 124. Academic Press, pp 114\u2013126"},{"issue":"1","key":"11412_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-017-9712-y","volume":"37","author":"J Kim","year":"2018","unstructured":"Kim J, Yao F, Xiao Z, Sun Y, Ma L (2018) MicroRNAs and metastasis: small RNAs play big roles. Cancer Metastasis Rev 37(1):5\u201315","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"11412_CR37","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1021\/acs.molpharmaceut.3c00309","volume":"20","author":"H Kumar","year":"2023","unstructured":"Kumar H, Chand P, Pachal S, Mallick S, Jain R, Madhunapantula SV, Jain V (2023) Fisetin-loaded nanostructured lipid carriers: formulation and evaluations against advanced and metastatic melanoma. Mol Pharm 20(12):6035\u20136055","journal-title":"Mol Pharm"},{"issue":"8","key":"11412_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00535-012-0547-6","volume":"47","author":"K Kurokawa","year":"2012","unstructured":"Kurokawa K, Tanahashi T, Iima T, Yamamoto Y, Akaike Y, Nishida K, Rokutan K (2012) Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells. J Gastroenterol 47(8):883\u2013895","journal-title":"J Gastroenterol"},{"issue":"5","key":"11412_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","volume":"8","author":"GD Leonard","year":"2003","unstructured":"Leonard GD, Fojo T, Bates SE (2003) The role of ABC transporters in clinical practice. Oncologist 8(5):411\u2013424","journal-title":"Oncologist"},{"issue":"1","key":"11412_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15\u201320","journal-title":"Cell"},{"key":"11412_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108611","volume":"112","author":"XN Li","year":"2019","unstructured":"Li XN, Wang ZJ, Ye CX, Zhao BC, Huang XX, Yang L (2019) Circular RNA circVAPA is up-regulated and exerts oncogenic properties by sponging miR-101 in colorectal cancer. Biomed Pharmacother 112:108611","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"11412_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/plants12142732","volume":"12","author":"S Liga","year":"2023","unstructured":"Liga S, Paul C, P\u00e9ter F (2023) Flavonoids: overview of biosynthesis, biological activity, and current extraction techniques. Plants 12(14):2732","journal-title":"Plants"},{"issue":"5","key":"11412_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri.2016.40","volume":"16","author":"A Mehta","year":"2016","unstructured":"Mehta A, Baltimore D (2016) MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol 16(5):279\u2013294","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"11412_CR44","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1080\/21655979.2021.1956672","volume":"12","author":"J Meng","year":"2021","unstructured":"Meng J, Song X, Yan G, Wang H, Li H, Lou D (2021) Dendrobine suppresses endoplasmic reticulum stress-induced apoptosis through upregulating microRNA miR-381-3p to decrease caspase-4. Bioengineered 12(1):4452\u20134463","journal-title":"Bioengineered"},{"issue":"2","key":"11412_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.drudis.2021.09.020","volume":"27","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Farahani MV, Hushmandi K, Orive G (2022) Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today 27(2):436\u2013455","journal-title":"Drug Discovery Today"},{"issue":"6","key":"11412_CR46","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3892\/or.2012.2059","volume":"28","author":"J Nishimura","year":"2012","unstructured":"Nishimura J, Handa R, Yamamoto H, Tanaka F, Shibata K, Mimori K, Mori M (2012) microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep 28(6):2221\u20132226","journal-title":"Oncol Rep"},{"key":"11412_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 9:402","journal-title":"Front Endocrinol"},{"key":"11412_CR48","doi-asserted-by":"publisher","first-page":"708765","DOI":"10.3389\/fonc.2021.708765","volume":"11","author":"K Otmani","year":"2021","unstructured":"Otmani K, Lewalle P (2021) Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol 11:708765","journal-title":"Front Oncol"},{"key":"11412_CR49","first-page":"105","volume-title":"Methods in cell biology","author":"F Otto","year":"1990","unstructured":"Otto F (1990) DAPI staining of fixed cells for high-resolution flow cytometry of nuclear DNA. Methods in cell biology, vol 33. Academic Press, pp 105\u2013110"},{"issue":"15_suppl","key":"11412_CR50","doi-asserted-by":"publisher","first-page":"e11010","DOI":"10.1200\/jco.2011.29.15_suppl.e11010","volume":"29","author":"A Ozgun","year":"2011","unstructured":"Ozgun A, Karagoz B, Bilgi O, Tuncel T, Kandemir EG (2011) MicroRNA-21 as an indicator of aggressive phenotype in breast cancer. J Clin Oncol 29(15_suppl):e11010\u2013e11010","journal-title":"J Clin Oncol"},{"issue":"2","key":"11412_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1677\/erc.1.01209","volume":"13","author":"P Pallante","year":"2006","unstructured":"Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Fusco A (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr-Relat Cancer 13(2):497\u2013508","journal-title":"Endocr-Relat Cancer"},{"issue":"9","key":"11412_CR52","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT\u2013PCR. Nucleic Acids Res 29(9):e45\u2013e45","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"11412_CR53","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ijpharm.2012.02.025","volume":"427","author":"H Ragelle","year":"2012","unstructured":"Ragelle H, Crauste-Manciet S, Seguin J, Brossard D, Scherman D, Arnaud P, Chabot GG (2012) Nanoemulsion formulation of fisetin improves bioavailability and antitumor activity in mice. Int J Pharm 427(2):452\u2013459","journal-title":"Int J Pharm"},{"key":"11412_CR54","doi-asserted-by":"publisher","first-page":"608686","DOI":"10.3389\/fimmu.2020.608686","volume":"11","author":"A Ricafrente","year":"2021","unstructured":"Ricafrente A, Nguyen H, Tran N, Donnelly S (2021) An evaluation of the Fasciola hepatica miRnome predicts a targeted regulation of mammalian innate immune responses. Front Immunol 11:608686","journal-title":"Front Immunol"},{"issue":"5","key":"11412_CR55","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorshid K, Fard HRS, S., Ghaffari SH (2019) An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol 234(5):5451\u20135465","journal-title":"J Cell Physiol"},{"issue":"4","key":"11412_CR56","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/jcmm.17161","volume":"26","author":"H Sha","year":"2022","unstructured":"Sha H, Gan Y, Xu F, Zhu Y, Zou R, Peng W, Feng J (2022) MicroRNA-381 in human cancer: Its involvement in tumor biology and clinical applications potential. J Cell Mol Med 26(4):977\u2013989","journal-title":"J Cell Mol Med"},{"key":"11412_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainres.2008.07.085","volume":"1236","author":"L Shi","year":"2008","unstructured":"Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y (2008) hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236:185\u2013193","journal-title":"Brain Res"},{"issue":"19","key":"11412_CR58","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","volume":"26","author":"ML Si","year":"2007","unstructured":"Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2007) miR-21-mediated tumor growth. Oncogene 26(19):2799\u20132803","journal-title":"Oncogene"},{"issue":"1","key":"11412_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","volume":"11","author":"W Si","year":"2019","unstructured":"Si W, Shen J, Zheng H, Fan W (2019) The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics 11(1):25","journal-title":"Clin Epigenetics"},{"issue":"5","key":"11412_CR60","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/mt.2013.35","volume":"21","author":"F Sicard","year":"2013","unstructured":"Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P (2013) Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther 21(5):986\u2013994","journal-title":"Mol Ther"},{"issue":"1","key":"11412_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. Cancer J Clin 68(1):7\u201330","journal-title":"Cancer J Clin"},{"key":"11412_CR62","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","volume-title":"Bioinformatics and computational biology solutions using R and Bioconductor","author":"GK Smyth","year":"2005","unstructured":"Smyth GK (2005) Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor. Springer New York, New York, pp 397\u2013420"},{"issue":"1","key":"11412_CR63","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1038\/s41598-020-65207-6","volume":"10","author":"LH Sun","year":"2020","unstructured":"Sun LH, Tian D, Yang ZC, Li JL (2020) Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4. Sci Rep 10(1):8271","journal-title":"Sci Rep"},{"issue":"13","key":"11412_CR64","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","volume":"76","author":"AA Svoronos","year":"2016","unstructured":"Svoronos AA, Engelman DM, Slack FJ (2016) OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Res 76(13):3666\u20133670","journal-title":"Cancer Res"},{"issue":"6","key":"11412_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24411","volume":"36","author":"W Tian","year":"2022","unstructured":"Tian W, Pang X, Luan F (2022) Diagnosis value of miR-181, miR\u2010652, and CA72\u20104 for gastric cancer. J Clin Lab Anal 36(6):e24411","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"11412_CR66","doi-asserted-by":"publisher","first-page":"188491","DOI":"10.1016\/j.bbcan.2020.188491","volume":"1875","author":"S Toden","year":"2021","unstructured":"Toden S, Zumwalt TJ, Goel A (2021) Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et Biophysica Acta (BBA)-Rev Cancer 1875(1):188491","journal-title":"Biochimica et Biophysica Acta (BBA)-Rev Cancer"},{"issue":"11","key":"11412_CR67","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.bcp.2011.07.097","volume":"82","author":"YS Touil","year":"2011","unstructured":"Touil YS, Auzeil N, Boulinguez F, Saighi H, Regazzetti A, Scherman D, Chabot GG (2011) Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite. Biochem Pharmacol 82(11):1731\u20131739","journal-title":"Biochem Pharmacol"},{"key":"11412_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther 206:107447","journal-title":"Pharmacol Ther"},{"key":"11412_CR69","doi-asserted-by":"crossref","unstructured":"Wang J, Zeng H, Li H, Chen T, Wang L, Zhang K, Wang S (2017a) MicroRNA-101 inhibits growth, proliferation and migration and induces apoptosis of breast cancer cells by targeting sex-determining region Y-Box 2. Cell Physiol Biochem 43(2):717\u2013732","DOI":"10.1159\/000481445"},{"key":"11412_CR70","doi-asserted-by":"crossref","unstructured":"Wang J, Seebacher N, Shi H, Kan Q, Duan Z (2017b) Novel strategies to prevent the development of multidrug resistance (MDR) in cancer. Oncotarget 8(48):84559","DOI":"10.18632\/oncotarget.19187"},{"issue":"1","key":"11412_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13148-018-0492-1","volume":"10","author":"H Wang","year":"2018","unstructured":"Wang H, Peng R, Wang J, Qin Z, Xue L (2018) Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clin Epigenetics 10(1):59","journal-title":"Clin Epigenetics"},{"key":"11412_CR72","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.mcp.2020.101567","volume":"52","author":"H Wang","year":"2020","unstructured":"Wang H, Guo Y, Mi N, Zhou L (2020) miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1. Mol Cell Probes 52:101567","journal-title":"Mol Cell Probes"},{"issue":"7","key":"11412_CR73","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1158\/1078-0432.CCR-05-1853","volume":"12","author":"Y Xi","year":"2006","unstructured":"Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J (2006) Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12(7):2014\u20132024","journal-title":"Clin Cancer Res"},{"issue":"1\u20132","key":"11412_CR74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000452525","volume":"40","author":"T Xie","year":"2016","unstructured":"Xie T, Huang M, Wang Y, Wang L, Chen C, Chu X (2016) MicroRNAs as regulators, biomarkers and therapeutic targets in the drug resistance of colorectal cancer. Cell Physiol Biochem 40(1\u20132):62\u201376","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"11412_CR75","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3892\/mmr.2013.1504","volume":"8","author":"D Xu","year":"2013","unstructured":"Xu D, Wang Q, An Y, Xu L (2013) miR\u2011203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Mol Med Rep 8(2):379\u2013384","journal-title":"Mol Med Rep"},{"issue":"2","key":"11412_CR76","first-page":"185","volume":"6","author":"P Yaffee","year":"2015","unstructured":"Yaffee P, Osipov A, Tan C, Tuli R, Hendifar A (2015) Review of systemic therapies for locally advanced and metastatic rectal cancer. J Gastrointest Oncol 6(2):185","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"11412_CR77","doi-asserted-by":"crossref","DOI":"10.62347\/DAZV7194","volume":"7","author":"X Yang","year":"2017","unstructured":"Yang X, Ruan H, Hu X, Cao A, Song L (2017) miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2. Am J Cancer Res 7(4):913","journal-title":"Am J Cancer Res"},{"issue":"1","key":"11412_CR78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12943-015-0372-7","volume":"14","author":"Y Yu","year":"2015","unstructured":"Yu Y, Nangia-Makker P, Farhana L, Rajendra G, Levi S, E., Majumdar AP (2015) miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Mol Cancer 14(1):98","journal-title":"Mol Cancer"},{"issue":"8","key":"11412_CR79","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1515\/hsz-2016-0308","volume":"398","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Wang J (2017) MicroRNAs are important regulators of drug resistance in colorectal cancer. Biol Chem 398(8):929\u2013938","journal-title":"Biol Chem"},{"issue":"1","key":"11412_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canlet.2013.08.037","volume":"342","author":"F Zhang","year":"2014","unstructured":"Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen X, Zeng Y (2014) MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett 342(1):121\u2013129","journal-title":"Cancer Lett"},{"issue":"3","key":"11412_CR81","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3892\/or.2015.4491","volume":"35","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Zhao S, Pang X, Chi B (2016) MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma. Oncol Rep 35(3):1831\u20131840","journal-title":"Oncol Rep"},{"key":"11412_CR82","doi-asserted-by":"crossref","unstructured":"Zhang H, Hu J, Fu R, Liu X, Zhang Y, Li J, Gao N (2018) Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3K\u03b3-mediated PI3K\/AKT\/mTOR\/p70S6K\/ULK signaling pathway in human breast cancer cells","DOI":"10.1038\/s41598-018-29308-7"},{"key":"11412_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmed.2020.00007","volume":"7","author":"T Zhang","year":"2020","unstructured":"Zhang T, Yang Z, Kusumanchi P, Han S, Liangpunsakul S (2020) Critical role of microRNA-21 in the pathogenesis of liver diseases. Front Med 7:7","journal-title":"Front Med"},{"issue":"5","key":"11412_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/and.14016","volume":"53","author":"W Zhao","year":"2021","unstructured":"Zhao W, Ning L, Wang L, Ouyang T, Qi L, Yang R, Wu Y (2021) miR-21 inhibition reverses doxorubicin\u2010resistance and inhibits PC3 human prostate cancer cells proliferation. Andrologia 53(5):e14016","journal-title":"Andrologia"},{"key":"11412_CR85","doi-asserted-by":"publisher","first-page":"116058","DOI":"10.1016\/j.bone.2021.116058","volume":"151","author":"H Zheng","year":"2021","unstructured":"Zheng H, Liu J, Yu J, McAlinden A (2021) Expression profiling of mitochondria-associated microRNAs during osteogenic differentiation of human MSCs. Bone 151:116058","journal-title":"Bone"},{"issue":"3","key":"11412_CR86","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/cam4.2764","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhang L, Zheng H, Ge W, Huang Y, Yan Y, Wang W (2020) Identification of chemoresistance-related mRNAs based on gemcitabine\u2010resistant pancreatic cancer cell lines. Cancer Med 9(3):1115\u20131130","journal-title":"Cancer Med"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11412-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11412-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:02:32Z","timestamp":1788685352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-026-11412-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11412"],"URL":"https:\/\/doi.org\/10.1007\/s10528-026-11412-3","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval is required.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}